NCT03066921 Evaluation Of The Efficacy of a Strain-Specific Probiotic Formulation in Hemodialysis Patients Status COMPLETED Phase NA
NCT03061552 Inferior Vena Cava Sonography in Hemodialysis Patients and Quality of Life Status COMPLETED Phase NA
NCT03004963 Bioimpedance-guided Fluid Management in Chronic Peritoneal Dialysis Patients. Status COMPLETED Phase NA
NCT02984124 Communication During Hospitalization About Resuscitation Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT02942407 Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation Status COMPLETED Phase PHASE4
NCT02933151 Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial) Status COMPLETED Phase NA
NCT02924298 Effect of Sit Less, Interact, Move More (SLIMM) Regimen on Patients With Chronic Kidney Disease (CKD) Status TERMINATED Phase NA
NCT02862717 Cost Utility Analysis of HD and CAPD in Ministry of Health Dialysis Centres, Malaysia Status COMPLETED Phase N/A
NCT02862197 Invasive Monitoring of Pulmonary Artery Pressure (PAP) Among Dialysis Treated Patients Status UNKNOWN Phase N/A
NCT02843334 Study of the Prevalence of Fabry Disease in French Dialysis Patients Status UNKNOWN Phase N/A
NCT02832466 Quantifying the Deterioration of Physical Function in Renal Patients Status COMPLETED Phase N/A
NCT02832440 Comparison of Two Exercise Programmes in Patients Undergoing Hemodialysis Status COMPLETED Phase NA
NCT02827435 Acute Pharmacokinetic-pharmacodynamic Change of Rocuronium After Reperfusion of Renal Graft Status RECRUITING Phase NA
NCT02743897 Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients Status COMPLETED Phase PHASE1/PHASE2
NCT02739100 Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients Status COMPLETED Phase PHASE1
NCT02738905 Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease Status WITHDRAWN Phase EARLY_PHASE1
NCT02695641 Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients Status WITHDRAWN Phase EARLY_PHASE1